Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [11C]NNC112

被引:20
|
作者
Thompson, Judy L. [1 ,5 ]
Rosell, Daniel R. [2 ,3 ]
Slifstein, Mark [1 ]
Girgis, Ragy R. [1 ]
Xu, Xiaoyan [1 ]
Ehrlich, Yosefa [2 ,3 ]
Kegeles, Lawrence S. [1 ,4 ]
Hazlett, Erin A. [2 ,3 ]
Abi-Dargham, Anissa [1 ,4 ]
Siever, Larry J. [2 ,3 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[3] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA
[4] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA
[5] Rutgers State Univ, Sch Hlth Related Profess, Scotch Plains, NJ 07076 USA
关键词
Schizotypal personality disorder; Schizophrenia; PET; Dopamine; Prefrontal cortex; Working memory; IN-VIVO BINDING; NEUROPSYCHOLOGICAL PERFORMANCE; SCHIZOPHRENIA SPECTRUM; NAIVE PATIENTS; D-1; RECEPTORS; TASK; SPECIFICITY; SELECTIVITY; TOMOGRAPHY; IMPAIRMENT;
D O I
10.1007/s00213-014-3566-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizotypal personality disorder (SPD) is associated with working memory (WM) impairments that are similar to those observed in schizophrenia. Imaging studies have suggested that schizophrenia is associated with alterations in dopamine D1 receptor availability in the prefrontal cortex (PFC) that may be related to the WM impairments that characterize this disorder. The aim of this study was to characterize prefrontal D1 receptor availability and its relation to WM performance in SPD. We used positron emission tomography (PET) and the radiotracer [C-11]NNC112 with 18 unmedicated SPD and 21 healthy control participants; as an index of D1 receptor availability, binding potential (BP) measures (BPF, BPND, and BPP) were calculated for prefrontal and striatal subregions. To assess WM, SPD participants completed the 2-back and Paced Auditory Serial Addition Test (PASAT). There were no significant group differences in PFC BP. BPF and BPP in the medial PFC were significantly negatively related to PASAT performance (r (s) = -0.551, p = .022 and r (s) = -0.488, p = .047, respectively), but BP was not related to 2-back performance. In contrast to what has been found in schizophrenia, SPD was not associated with significant alterations in prefrontal D1 receptor availability. Similar to previous schizophrenia findings, however, higher prefrontal D1 receptor availability was associated with poorer WM performance (as measured by the PASAT) in SPD. These findings suggest that schizophrenia and SPD may share a common pathophysiological feature related to prefrontal dopamine functioning that contributes to WM dysfunction, but that in SPD, alterations in D1 may occur only in a subset of individuals and/or to an extent that is minor relative to what occurs in schizophrenia.
引用
收藏
页码:4231 / 4240
页数:10
相关论文
共 50 条
  • [31] Chronic NMDA Antagonism Impairs Working Memory, Decreases Extracellular Dopamine, and Increases D1 Receptor Binding in Prefrontal Cortex of Conscious Monkeys
    Hideo Tsukada
    Shingo Nishiyama
    Dai Fukumoto
    Kengo Sato
    Takeharu Kakiuchi
    Edward F Domino
    Neuropsychopharmacology, 2005, 30 : 1861 - 1869
  • [32] Dopamine D1 agonist R-[11C]SKF 82957:: Synthesis and in vivo characterization in rats
    DaSilva, JN
    Schwartz, RA
    Greenwald, ER
    Lourenco, CM
    Wilson, AA
    Houle, S
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (05) : 537 - 542
  • [33] Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson’s diseaseA [11C]-raclopride PET study
    S. Thobois
    V. Fraix
    M. Savasta
    N. Costes
    P. Pollak
    P. Mertens
    A. Koudsie
    D. Le Bars
    A. L. Benabid
    E. Broussolle
    Journal of Neurology, 2003, 250 : 1219 - 1223
  • [34] Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease:: A comparative PET study with [11C]raclopride and [11C]N-methylspiperone
    Kaasinen, V
    Ruottinen, HM
    Någren, K
    Lehikoinen, P
    Oikonen, T
    Rinne, JO
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (01) : 65 - 70
  • [35] Working memory processes and the histamine-3 receptor in schizophrenia: a [11C]MK-8278 PET-fMRI study
    Arumuham, Atheeshaan
    Shatalina, Ekaterina
    Nour, Matthew M.
    Veronese, Mattia
    Onwordi, Ellis Chika
    Kaar, Stephen J.
    Jauhar, Sameer
    Rabiner, Eugenii A.
    Howes, Oliver D.
    PSYCHOPHARMACOLOGY, 2024, : 1321 - 1334
  • [36] Dopamine D2 and D3 Receptor Availability in Antipsychotic-free patients with Schizophrenia in Later Life: A Cross-sectional [11C]-(+)-PHNO and [11C]-raclopride PET Study
    Nakajima, Shinichiro
    Caravaggio, Fernando
    Mamo, David C.
    Mulsant, Benoit H.
    Chung, Jun Ku
    Plitman, Eric
    Iwata, Yusuke
    Gerretsen, Philip
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Mar, Wanna
    Wilson, Alan A.
    Houle, Sylvain
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 118S - 118S
  • [37] The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
    Ariel Graff-Guerrero
    Romina Mizrahi
    Ofer Agid
    Heidi Marcon
    Penny Barsoum
    Pablo Rusjan
    Alan A Wilson
    Robert Zipursky
    Shitij Kapur
    Neuropsychopharmacology, 2009, 34 : 1078 - 1086
  • [38] Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease:: PET studies with [11C]NNC 112 and [18F]FDOPA
    Cropley, Vanessa L.
    Fujita, Masahiro
    Bara-Jimenez, William
    Brown, Amira K.
    Zhang, Xiang-Yang
    Sangare, Janet
    Herscovitch, Peter
    Pike, Victor W.
    Hallett, Mark
    Nathan, Pradeep J.
    Innis, Robert B.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2008, 163 (02) : 171 - 182
  • [39] The dopamine D1 but not D3 receptor plays a fundamental role in spatial working memory and BDNF expression in prefrontal cortex of mice
    Xing, Bo
    Guo, Juan
    Meng, Xia
    Wei, Shu-guang
    Li, Sheng-bin
    BEHAVIOURAL BRAIN RESEARCH, 2012, 235 (01) : 36 - 41
  • [40] Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET
    Hirvonen, Jussi
    Karlsson, Hasse
    Kajander, Jaana
    Markkula, Juha
    Rasi-Hakala, Helena
    Nagren, Kjell
    Salminen, Jouko K.
    Hietala, Jarmo
    PSYCHOPHARMACOLOGY, 2008, 197 (04) : 581 - 590